Skip to content

Cardiac sympathetic activity in 22q11 deletion syndrome.

Cardiac sympathetic activity in 22q11 deletion syndrome. - Cardiac sympathetic activity in 22q11 deletion syndrome.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35870
Enrollment
20
Registered
2011-11-24
Start date
2012-12-05
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiale sympathische activiteit cardiac nerve activity cardiac sympathetic innervation

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients with the 22q11 deletion syndrome, confirmed by genetic analysis

Exclusion criteria

Exclusion criteria: - Congenital hart disease - Use of medication that might influence dopamine and norepinephrine concentrations - Pregnancy - Known allergy to iodine

Design outcomes

Primary

MeasureTime frame
Difference in cardiac sympathetic activity as assessed with 123I-MIBG between subject with 22q11DS and healthy subjects, with and without cathecholamine depletion.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)